REGENERON PHARMACEUTICALS, INC.
SEC Filing List
REGN CIK: 0000872589
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Regeneron Pharmaceuticals, Inc. | 10/30/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 10/30/2026 | ||
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 10/30/2026 | ||
| 8-K | Current report filing | Regeneron Pharmaceuticals, Inc. | 10/30/2026 | ||
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 10/30/2026 | ||
| 4 | Statement of changes in beneficial owner... | Murphy Andrew J | Regeneron Pharmaceuticals, Inc. | 10/15/2026 | |
| 144 | Filing for proposed sale of securities u... | UBS Financial Services Inc Restricted Sale Group / FA /fa | 10/14/2026 | ||
| 8-K | Current report filing | Regeneron Pharmaceuticals, Inc. | Toppan Merrill/FA | 10/06/2026 | |
| 8-K | Current report filing | Regeneron Pharmaceuticals, Inc. | Toppan Merrill/FA | 09/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Guarini Kathryn | Regeneron Pharmaceuticals, Inc. | 09/03/2026 | |
| No record found. | |||||
| Load More | |||||
